KH7 選擇性抑製劑 | soluble adenylyl cyclase inhibitor 貨號2350-25

| 代理廠牌: | ![]() |
| 原廠連結: | |
| 相關下載: |
特點
KH7 | SAC選擇性抑製劑 | 貨號2350-25
soluble adenylyl cyclase選擇性抑製劑(SAC)(IC 50=3-10μM體內)

A selective inhibitor of soluble adenylyl cyclase (sAC) ( IC₅₀ = 3-10 µM in vivo). Displays little effect on transmembrane adenylyl cyclases. KH7 is not active against sAC in the presence of detergents. At concentrations above 50 µM, KH7 exhibits non-specific membrane disruption effects when used on cells. 分子型式 C17H15BrN4O2S | 分子量Molecular Weight: 419.3 | 純度Purity: ≥98% by HPLC | Solubility: DMSO (~40 mg/ml)
| Catalog # | Product Name+ | Size |
| 2770-5 | 2′,5′-Dideoxyadenosine | 5 mg |
| 2770-25 | 2′,5′-Dideoxyadenosine | 25 mg |
| 2350-5 | KH7 | 5 mg |
| 2350-25 | KH7 | 25 mg |
| 2019-5 | SQ 22536 | 5 mg |
| 2019-25 | SQ 22536 | 25 mg |
